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Abstract
Background: Haematogenous Staphylococcus aureus meningitis is rare but associated with high
mortality. Knowledge about the disease is still limited. The objective of this study was to evaluate
demographic and clinical prognostic features of bacteraemic S. aureus meningitis.
Methods: Nationwide surveillance in Denmark from 1991 to 2000 with clinical and bacteriological
data. Risks of death were estimated by Cox proportional hazards regression analysis.
Results: Among 12480 cases of S. aureus bacteraemia/sepsis, we identified 96 cases of non-surgical
bacteraemic S. aureus meningitis (0.8%). Incidence rates were 0.24 (95% confidence interval [CI],
0.18 to 0.30)/100 000 population between 1991–1995 and 0.13 (CI, 0.08 to 0.17)/100 000
population between 1996–2000. Mortality was 56%. After adjustment, only co morbidity (hazard
ratio [HR], 3.45; CI, 1.15 to 10.30) and critical illness (Pitt score ≥ 4) (HR, 2.14; CI, 1.09 to 4.19)
remained independent predictors of mortality.
Conclusion: The incidence, but not mortality of bacteraemic S. aureus meningitis decreased during
the study period. Co morbidity and critical illness were independent predictors of a poor outcome.
Background
Spontaneous, non-surgical meningitis caused by Staphylo-
coccus aureus is a rare disease with an annual incidence in
Denmark of 0.22 per 100 000 population[1]. Mortality
rates (50%) are higher than for other types of bacterial
meningitis [1-3]. Age, diabetes mellitus, disseminated
intravascular coagulation[4], impaired consciousness on
presentation[4,5], presence of shock and infection with
phage type 95[1] have all been associated with a poor out-
come by an univariate statistical analysis.
Two different modes of S aureus meningitis pathogenesis
have been considered in the literature: hospital-acquired
infection with a positive blood culture and evidence of
infection later than 48 hours after admission, often asso-
ciated with either head trauma or neurosurgical proce-
dures, or a community-acquired infection with a positive
blood culture and evidence of infection less than 48 hours
after admission, in the absence of any recent head trauma
or surgical procedures i.e. due to an infection outside the
central nervous system[1,3-6]. Most studies have evalu-
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ated both surgically introduced and spontaneous S aureus
meningitis cases[1,3-6]. However, there is a considerable
difference between the two groups, e.g. as regards mortal-
ity, age and frequency of metastatic infections[1,3,4,7]. To
our knowledge there has never been a review of a large
number of haematogenous i.e. community-acquired
bacteraemic S aureus meningitis cases exclusively.
Predictors of meningitis and outcome have an impact on
patient management. The proper antibiotic treatment has
been considered in several studies[1,3-5,8]; however, the
optimal antibiotic recommendation remains unclear.
Here we evaluate demographic features and clinical varia-
bles of prognostic influence on the outcome of haematog-
enous S aureus meningitis.
Methods
Selection of cases
The Staphylococcal Laboratory, Statens Serum Institut,
Copenhagen, annually receives almost all S aureus blood
culture strains for phage typing and resistance surveillance
from all clinical microbiology departments in Denmark.
In addition discharge summaries from all episodes are
collected. In cases with clinical evidence of meningitis and
verified  S aureus aetiology, the medical records were
obtained from the relevant clinical department and
reviewed. The diagnosis was based on the following crite-
ria: (i) characteristic clinical findings; (ii) bacterial cul-
tures of CSF and/or blood showing S aureus; (iii) CSF
leukocyte count > 50 * 106/l with > 80% neutrophils. In
cases with a negative CSF culture, a positive blood culture
with S aureus and CSF pleocytosis was considered indica-
tive for S aureus meningitis [5]. Cases with clinical find-
ings were included if an identical strain was identified in
CSF and blood cultures. Population data was obtained
from Danmarks Statistik [9].
Definitions and clinical data
For all cases the following data were registered: Age, sex,
blood cultures results, overall survival or in-hospital death
of the patient, old people's home residence (a home out-
side of the hospital for people over 65 years of age who
require full-time care). Alcohol consumption, tobacco
use, symptoms and clinical signs, temperature, blood
pressure, heart rate, which was uniformly taken from the
time of admittance to the hospital. Recent surgery (< 4
weeks), primary and secondary focus. Primary focus of
infection was based on evident clinical signs and/or symp-
toms that were later confirmed by cultivation of a bacte-
rial strain with the same resistance pattern as the blood
culture strain. Endocarditis, osteomyelitis, arthritis and
meningitis were considered secondary foci if the patient
had not received surgical intervention at these sites prior
to the onset of S aureus bacteremia. Co morbidity was
divided in categories of competing illnesses. They were
cardiac illness, pulmonary illness, diabetes, alcoholism,
neurological illness, reumatological illness, renal illness,
gastrointestinal malignancy and other immunosuppres-
sion. Co morbidity was registered and for the statistical
calculations divided in none, one or more than one pre-
disposing condition.
Classification of meningitis cases and exclusions
Meningitis was classified as community-acquired, noso-
comial or health care associated. Meningitis was defined
as community acquired, if diagnosed with a positive
blood culture < 48 hr. after hospitalisation in patients
with no regular contact with the hospital, with clinical evi-
dence of infection and if the patient had not received sur-
gical intervention within the preceding four weeks.
Nosocomial meningitis was defined as a hospital acquired
meningitis > 48 hr. after hospitalisation. Meningitis was
defined as health care associated, if diagnosed < 48 hr.
after hospitalisation in patients with regular contact with
the hospital e.g. in an out-patients' clinic. It the cases were
not classifiable in one of the three above-mentioned cate-
gories they were excluded from the study.
Laboratory data
Also a registration of date of the lumbar puncture, cere-
brospinal fluid (CSF) microscopy and culture, CSF glu-
cose, CSF protein, serum glucose, CSF cell count and the
blood biochemistry variables pH, red and white blood
cell count, platelets, CRP, potassium, sodium, creatinine,
and carbamide was done. All the different image diagnos-
tics were listed.
Severity of illness
Whether there was a need for transfer to intensive care
unit, for vasopressor support, mechanical ventilation or
dialysis was noted. An APACHE (Acute Physiology, Age
and Chronic Health Evaluation) II score could not be per-
formed retrospectively. Instead we calculated the Pitt
bacteraemia score that assesses the severity of illness[10].
Antimicrobial treatment
Initial antibiotic treatment and duration, whether the ini-
tial treatment was relevant and eventual change of antibi-
otics was registered together with bacterial resistance.
Initial treatment was defined as the first antibiotic therapy
the patient received when submitted to the hospital i.e.
prior to the microbiological verification of the bacterial
infection. The treatment was considered appropriate if the
S aureus strain was found susceptible to the antimicrobial
treatment administered.
Bacteriology
Susceptibility to antibiotics of the infecting strains was
determined by a disk diffusion method[1]. The testing
comprised susceptibility to penicillin, streptomycin, tetra-BMC Infectious Diseases 2006, 6:49 http://www.biomedcentral.com/1471-2334/6/49
Page 3 of 7
(page number not for citation purposes)
cycline, erythromycin, methicillin, fusidic acid, cipro-
floxacine and gentamicin.
Statistical analysis
All values are expressed as median and range. Differences
between groups were estimated by Mann-Whitney test or
χ2 statistics, as appropriate. P < 0.05 was considered signif-
icant. Cox proportional hazard regression analysis was
used to estimate hazard ratio associated with outcome.
The likelihood ratio test was used to test for interaction.
There were no significant interactions. The adequacy of
the model was checked by testing the proportional haz-
ards assumption in different ways: by conducting the tra-
ditional graphics check based on the log of the cumulative
hazard and by performing a formal test of proportionality
based on Schoenfeld residuals according to the method of
Hosmer and Lemeshow [11]. Statistical analysis was per-
formed with SPSS 11.5 (Statistical Package for Social Sci-
ences, Chicago, IL.) and Stata Statistical Software (version
9.0; Stata Corporation, College Station, TX). P < 0.05 on a
two-sided test was considered significant.
Limitations of study design
Cases were identified prospectively but detailed chart data
was extracted retrospectively. Therefore, some factors that
influence outcome may not have been captured and we
cannot exclude the possibility of residual confounding.
Although, this is the largest published data set of S aureus
meningitis, the low number of cases may have limited the
multivariate analysis.
Ethical approval
The study was approved by the ethical committee for
Copenhagen and Frederiksberg Counties (01-369/93).
Results
Patient characteristics
During the whole study period from 1991 to 2000, 12480
cases of S. aureus bacteraemia were received. Of these, 107
patients with bacteraemic S. aureus meningitis were iden-
tified. Eleven cases were surgical infections and therefore
excluded from analysis. Of the remaining 96 patients with
haematogenous S. aureus meningitis, 81 cases were com-
munity-acquired, ten cases were nosocomial and five
cases health care associated. The total incidence for the
period 1991–2000 was 0,18 (95% confidence interval
[CI], 0,15–0,22)/100 000 population. However, the inci-
dence declined through the study period. For the period
1991–1995 it was 0,24 (CI, 0,18–0,3)/100 000 popula-
tion and for 1996–2000 it was 0,13 (CI, 0,08–0,17)/100
000. The sex distribution was 42 (44%) men and 54
(56%) women. Although the median age was high (67
years, range (0–97)), only two patients came from an old
people's home and 12 patients were intravenous drug
users. In 95 assessable cases, 58 (61%) had an unknown
primary focus, whereas 39% had foci in skin, lungs or uri-
nary tract. In 57 cases there were a secondary focus in
addition to meningitis and of these patients, 35 (61%)
had endocarditis, 17 (30%) had osteomyelitis and 5 (9%)
had other secondary focus. Of 64 patients, 34 (53%) were
smokers and 13 of 61 patients (21%) consumed excess
amounts of alcohol. Of 95 patients 11 (12%) had diabe-
tes. At presentation the majority of the patients (85%; 71/
84 patients) had fever, 24% (22/92) had headache, 17%
(16/92) had vomiting and 4% (4/92) had seizures. Of 89
patients, 66 (74%) had changes in mental status, 58
(65%) had nuchal rigidity and 17 (19%) focal neurologi-
cal findings. 20% (18/89) had a rash. 56% (54/96) of the
patients died during admittance.
Laboratory characteristics at admission
Laboratory characteristics of the patients are shown in
Table 1. Temperature and paraclinical findings were not
significantly different between survivors and non-survi-
vors, except for blood-glucose, which was lower for survi-
vors (median, 6,9 (range, 5–11) mmol/l vs. median 8,4
(range, 6–35) mmol/l) (N = 36) (P = 0,048) (Table 1).
The cerebrospinal fluid white blood cell count was 148 *
106/l (range, 1–13870 * 106/l) (N = 66), with 90% poly-
morph nuclear neutrophils (range, 40–100%) (N = 48).
In 4 cases the lumbar puncture results were unavailable. S
aureus was seen in the spinal fluid in 15 of 55 (27%) cases
by microscopy. Of 73 cases with available information, 53
(73%) had a spinal fluid with a positive bacterial culture.
Treatment of meningitis
As expected in Scandinavia, all but one of the 96 S aureus
strains were methicillin-sensitive (MSSA), whereas 87
(90%) were resistant to penicillin, three strains were
resistant to tetracycline, two to ciprofloxacin, two to strep-
tomycin and one to erythromycin. The initial empiric
treatment is illustrated in Table 2. Initially, 57 (61%) of
the 93 patients were treated with penicillin or ampicillin
with or without an amino-glycoside. In 3 cases informa-
tion about the initial treatment were unavailable. The ini-
tial treatment was considered inappropriate in 53 (61%)
of the 87 cases, since all 53 strains were penicillin resistant
and aminoglycoside was not expected to sterilize CSF. Of
these, 33 (62%) died. The initial treatment was appropri-
ate in 34 (39%) of the cases and among these, 18 (53%)
died. In 9 cases it was not possible to evaluate whether the
initial treatment was relevant. However, there was no sig-
nificant difference in survival between patients who
received an appropriate and an inappropriate treatment
(p > 0,2) (N = 87). When the diagnosis of S aureus menin-
gitis was established, the treatment was changed in 81
(84%) of the 96 cases to specific anti-staphylococcal ther-
apy. After bacterial diagnosis 41 (77%) of the initial 53
patients receiving an inappropriate treatment were change
to an appropriate treatment. After bacterial diagnosis andBMC Infectious Diseases 2006, 6:49 http://www.biomedcentral.com/1471-2334/6/49
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susceptibility testing, 82 (90%) of the 91 patients then
received an appropriate antibiotic treatment and 9 (10%)
an inappropriate treatment. There was no significant dif-
ference in mortality between the two groups (p > 0,5) (N
= 91). In 5 cases there were no information about the anti-
biotic treatment after the bacterial diagnosis.
Mortality
The importance of risk factors for mortality in univariate
and multivariate analysis are shown in Table 3. Fifty-four
of the 96 patients died (56%). To explore the risk of pro-
gression to death associated with baseline variables, each
variable was entered in a Cox regression model by univar-
iate analysis. Age above 65 yr., co-morbidity (one or more
predisposing diseases) and critical illness defined by Pitt
score >3 each were univariately associated with an
increased mortality, while intravenous drug use was uni-
variately associated with a decreased mortality (Table 3).
The following variables were not associated with mortal-
ity: alcohol consumption, tobacco use, portal of entry of
the bacteria, vasoactive support, mechanical ventilation,
dialysis, and whether the patient was recently operated.
Also, there was no relation between mortality and endo-
carditis or osteomyelitis compared with the group not
having endocarditis or osteomyelitis. By multivariate
analysis only co morbidity and critical illness remained
independent predictors of survival (Table 3).
Discussion
As the incidence of both community-acquired and noso-
comial S aureus bacteraemia increased during the study
period, we anticipated an increase in haematogenous S
aureus meningitis cases, but observed a reduction. This
could be explained by either an earlier detection and treat-
ment of S aureus bacteraemia thus preventing spread, mis-
diagnoses or an unbalanced under-reporting of the
meningitis cases[12]. Of note, this series only comprise
bacteraemic cases, which is estimated to be only 80% of
all S aureus meningitis cases[1]. S aureus meningitis is an
uncommon infection, accounting for approximately 2,6%
of all bacterial meningitis[5], but the number of cases is
probably underreported[12].
During a ten-year period from 1991 to 2000, we identified
96 cases of spontaneous S aureus meningitis, which to our
knowledge is the largest reported series of haematogenous
S aureus meningitis. These cases occurred among 12480
patients with S aureus bacteraemia (0,8%). As also
reported by other groups, the patients have an advanced
age and a short history of symptoms before admission to
hospital[1,5]. Contrary to other S aureus meningitis stud-
ies, using univariate analysis, we do not find age to be a
risk factor for death[1,4,5,7,8]. Also in coagulase-negative
staphylococcal meningitis[13], tuberculosis meningi-
tis[14] and Streptococcus pneumoniae meningitis[15]
advanced age has been found to be associated with poor
outcome by univariate analysis. However, patients with
advanced age have more competing illnesses[16], which
could explain that age is not significant in a multivariate
test, as competing illnesses might have a larger impact on
the patients overall health status when having meningitis.
S aureus may only penetrate/cross the blood brain barrier
with difficulty. Studies suggest that S aureus is a non-inva-
sive extracellular pathogen that damages host cells after
adhering to the extra cellular matrix[17]. However, infec-
tions with large bacterial loads and of considerable dura-
tion may promote development of meningitis. In support
of this, a significant number of the patients (60%) had
other secondary focuses such as endocarditis (36%) or
Table 1: Demographic and Laboratory Characteristics of Patients with S. aureus meningitis according to survival.
Chraracteristics All Patients (N = 96) Survivors (N = 42) Non-survivors (N = 54) P value
Age, yr 67 (0–97) 54 (0–97) 72 (35–90) <0.001
Male/female gender, No 42/54 20/21 22/33 = 0.50
Cell count, total 149 (1–13870) 105 (2–2410) 196 (1–13870) = 0.097
Cell count, %polymorphnuclear 90 (40–100) (N = 46) 86 (40–100) (N = 19) 90 (50–100) (N = 27) = 0.47
S-glucose, mmol/l 7.6 (5–35) (N = 36) 6.9 (5–11) (N = 15) 8.4 (6–35) (N = 21) = 0.048
CRP, mg/l 245 (25–459) (N = 32) 258 (25–392) (N = 15) 222 (138–459) (N = 17) = 0.48
Initial treatment, No
Relevant 34 16 18
Irrelevant 53 20 33 = 0.27
Pitt score≥4, No 56 16 40 = 0.006
Other secundary focus, No 57 28 29 = 0.35
Intra-veneous drug use, No 12 9 3 = 0.028
Comorbidity, No
None 26 5 21
13 6 2 4 1 2
>1 35 26 9 <0.001
Unless otherwise indicated, data are presented as No. or median (range).BMC Infectious Diseases 2006, 6:49 http://www.biomedcentral.com/1471-2334/6/49
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osteomyelitis (16%), making these conditions important
risk factors for meningitis. Patients with either S aureus
endocarditis or osteomyelitis characteristically present
non-specific, vague and diffuse symptoms[18,19]. There-
fore, the duration of time the microorganisms (S aureus)
are present in the blood could be of importance, as has
been found for tuberculosis meningitis[14], even if the
bacterial count is low[20]. Also, an earlier study shows
that patients with endocarditis have an increased mortal-
ity if they have neurological manifestations, including
meningitis[21]. This supports a recommendation that
patients with S aureus meningitis should all be examined
for both endocarditis[21,22] and osteomyelitis[23]. In
our patients, however, simultaneous endocaditis or osteo-
myelitis did not influence survival.
Diabetes mellitus is associated with increased rates of S
aureus colonization and infection risk[18]. In the present
study survivors had lower blood glucose than the non-sur-
vivor, but this could not be estimated in multivariate
models because only a minority had available blood glu-
cose values. In our series there were more patients with
hyperglycaemia than had a known diagnosis of diabetes
(Table 1). Whether the patients had hyperglycaemia as a
predisposing factor to the infection or whether they have
hyperglycaemia as a consequence of the stress response
Table 3: Uni- and multivariate analysis of risk factors associated with in-hospital death from S aureus meningitis.
Univariate HR (95% CI) Multivariate HR (95% CI) p value (Multivariate)
Age, > 65 years 2.65 (1.47–4.78) 1.57 (0.79–3.13) 0.20
Comorbidity 5.13 (2.03–12.96) 3.45 (1.15–10.30) 0.03
Intravenous drug use 0.31 (0.10–0.99) 0.64 (0.16–2.53) 0.53
Critical illness (Pitt score > 3) 2.58 (1.37–4.93) 2.14 (1.09–4.19) 0.03
HR: hazard ratio. CI: confidence interval. Cox regression with all variables foced into the model. HRs are adjusted with all variables including in the 
model.
Table 2: Initial antibiotic treatment in S. aureus meningitis.
Antibiotics Number, total Number of deaths
Inappropriate antibiotic treatment:
Ampicillin 4 2
Ampicillin+gentamicin 12 5
Erythromycin 1 1
Penicillin 32 22
Penicillin+gentamicin 3 2
Ampicillin+cefotaxim* 1 1
Mortality in the group 62%
Relevant antibiotic treatment:
Methicilline 3 1
Methicilline+fusidic acid 2 1
Dicloxacillin 4 0
Dicloxacillin+rifampin 1 1
Dicloxacillin+fusidic acid 1 0
Ceftriaxone 12 5
Vancomycin+ceftriaxone 1 1
Vancomycin+fusidic acid 1 1
Cefuroxime 3 3
Ampicillin** 3 3
Ampicillin+chloramphenicol** 1 0
Penicillin** 2 2
Mortality in the group 5%
Total, No. 87 51
* MRSA strain. ** Penicillin sensitive strains. Mortality between the two groups is not significantly different (P > 0,2).BMC Infectious Diseases 2006, 6:49 http://www.biomedcentral.com/1471-2334/6/49
Page 6 of 7
(page number not for citation purposes)
caused by the massive infection, the data did not indicate
further[24]. Diabetes mellitus is a predictor of poor out-
come in earlier studies of both S aureus bacteraemia and
meningitis [25-27]. Hyperglycaemia is known to be asso-
ciated with increased mortality and significant impair-
ment in functional recovery in patients with cerebral
ischaemia[28]. The mechanism is not well defined, but
hyperglycaemia does induce cerebral oedema and blood-
brain-barrier defect[29]. It is possible that a tight glycae-
mic control in these patients may be beneficial and
should be the subject of future research[29].
The appropriate antibiotic treatment for S aureus meningi-
tis has been debated through out the litera-
ture[1,3,4,8,12,30]. In spite of the many cases, our case
series proved to be to small for a recommendation by
multivariate analysis. Initially the majority of the patients
received an inappropriate antibiotic anti-staphylococcal
treatment due to the fact that staphylococcal infection was
not suspected and that, in Denmark, the guidelines rec-
ommend a penicillin for empirical treatment of infections
prior to susceptibility testing, because a community-
acquired infection usually predicts susceptibility penicil-
lins [12]. Therefore, as for outcome, the optimal anti-sta-
phylococcal treatment remains unclear.
Mortality is still very high (56%) and unchanged com-
pared to earlier S aureus meningitis surveys[1,3,19]. In
large surveys of adults with bacterial meningitis, pneumo-
coccal meningitis is emphasized because of mortality rate
of approximately 30 percent[2,31]. Although S aureus
meningitis cases are few in numbers[1,12,31], they
should be considered as a possible aetiology in the initial
management in order to improve outcome[32]. Knowl-
edge of the causative organism of meningitis is important
in predicting the risk of an unfavourable outcome.
Patients are critically ill at admission, but there was no
direct association between survival and admission to an
intensive care unit in this study. Co morbidity and critical
illness (Pitt score ≥ 4) were independently associated with
risk of death. The prognosis was poor both if the patient
had just one predisposing condition and if there where
more than one. It is of importance for outcome whether
the patients are seriously chronic ill at the onset of menin-
gitis, a finding that Mylotte and Tayara[26] find in a
cohort of S aureus bacteraemia. Special attention should
be given patients with the presence of underlying disease,
as this risk factor is strong in our study and in other stud-
ies of both bacterial meningitis in general and of S aureus
meningitis[7,31].
Conclusion
The incidence of S aureus meningitis decreased during the
study period, although the number of bacteraemia
increased. By multivariate analysis only co morbidity and
critical illness were independent predictors of outcome.
Advanced age was not a risk factor for death. Our recom-
mendations to improve diagnosis and potentially the
prognosis of patients with S aureus meningitis would be,
to evaluate patients who have a positive S aureus culture
or with a suspicion of invasive S aureus infection for signs
and symptoms of meningitis. Verified cases should be
closely evaluated for other secondary foci especially endo-
carditis and osteomyelitis.
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